Watchlist Price Alert

Inhibikase Therapeutics I... (IKT)

NASDAQ: IKT · Real-Time Price · USD

2.02

0.01 (0.50%)

At close: Jun 02, 2025, 1:53 PM

Inhibikase Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-27.52M	-19.03M	-18.05M	-14.79M	-2.85M	-5.72M	-2.15M	-436.07K	-628.74K
Depreciation & Amortization	26.27K	177.4K	6.72K	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	8.14M	500.15K	458.15K	1.53M	573.7K	1.44M	642.23K	300.66K	310.09K
Other Working Capital	-66.85K	699.28K	39.53K	-2.33M	-217.57K	1.17M	256.73K	159.41K	98.91K
Other Non-Cash Items	n/a	31.54K	67K	721.63K	1.61M	2.32M	709.27K	534.62K	95.71K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	204.93K	234.76K	171.18K	-1.76M	-464.64K	1.63M	1.52M	-32.76K	193.36K
Operating Cash Flow	-19.15M	-18.09M	-17.35M	-14.3M	-1.13M	-338.29K	714.99K	-126.39K	-29.57K
Capital Expenditures	n/a	-14.24K	-243.25K	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	243.25K	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-60.46M	-29.43M	-20.73M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	23.45M	41.1M	4.96M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-243.25K	n/a	n/a	n/a	87.1K	n/a	n/a
Investing Cash Flow	-37M	11.66M	-16.01M	n/a	n/a	n/a	87.1K	n/a	n/a
Debt Repayment	n/a	n/a	-248.91K	-42.53K	272.8K	-22.81K	-26.31K	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	848.00	n/a	n/a	-1.59M	131.02K	-23.77K
Financial Cash Flow	103.48M	8.41M	-204.77K	41.09M	15.06M	-22.81K	-439.19K	131.02K	-23.77K
Net Cash Flow	47.33M	1.98M	-33.56M	26.8M	13.94M	-361.1K	362.89K	4.63K	-53.34K
Free Cash Flow	-19.15M	-18.1M	-17.59M	-14.3M	-1.13M	-338.29K	714.99K	-126.39K	-29.57K